Ian Taylor - 23 Feb 2024 Form 4 Insider Report for ARVINAS, INC. (ARVN)

Role
Chief Scientific Officer
Signature
/s/ Jared Freedberg, as attorney-in-fact for Ian Taylor
Issuer symbol
ARVN
Transactions as of
23 Feb 2024
Net transactions value
-$80,032
Form type
4
Filing time
27 Feb 2024, 18:33:43 UTC
Previous filing
08 Jan 2024
Next filing
18 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARVN Common Stock Award $0 +39,250 +36% $0.000000 149,223 23 Feb 2024 Direct F1
transaction ARVN Common Stock Sale $80,032 -1,701 -1.1% $47.05 147,522 23 Feb 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARVN Stock Option (right to buy) Award $0 +58,100 $0.000000 58,100 23 Feb 2024 Common Stock 58,100 $47.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units (each, an "RSU") were granted by the Issuer on February 23, 2024, pursuant to its 2018 Stock Incentive Plan (the "Plan") and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs will vest over two years: 1/2 of the shares underlying the award shall vest on February 23, 2025, with the remainder of the shares vesting in on February 23, 2026.
F2 This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units.
F3 The option was granted by the Issuer on February 23, 2024, pursuant to the Plan. The shares underlying the option will vest over two years: 1/2 of the shares underlying the award shall vest on February 23, 2025, with the remainder of the shares vesting on February 23, 2026.